Sequent Scientific, Viyash Life Sciences announce Rs 8,000 crore merger

Sequent Scientific and Viyash Life Sciences have announced a merger, creating a platform with leadership in animal pharmaceuticals and integrated capabilities across the global pharmaceutical market. The merger will expand Sequent's capital base and is expected to enhance marketing presence, facilitate backward integration, and create procurement synergies.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Epe2y4F
via IFTTT